uniQure N.V.
AMT-130
Huntington’s disease
Countdown
86days
Approval decision · ~ Sep 30, 2026 estimated
What's at stake
A final FDA approval decision on AMT-130 for Huntington’s disease is expected ~ Sep 30, 2026.
Primary source
· SEC 8-K
verified 11h ago
“The Company intends to submit the BLA in third quarter of 2026.”